Pereira CJ, Pereira RY, Quirós FL

Language: Spanish
References: 16
Page: 345
PDF size: 157.73 Kb.

ABSTRACT

Preeclampsia, is part of the neurohypertensive disorders of pregnancy, characteristics due to the presence of proteinuria plus arterial hypertension during pregnancy, in addition, it is associated with high maternal and fetal morbidity and mortality. Some risk factors predispose to suffer from this disorder, and therefore, an appropriate clinical evaluation must be established for each patient, in order to identify the preventive measures that have been obtained through studies conducted, with the aim of reducing the incidence of preeclampsia, in addition to reducing its negative impact and the final perinatological result. Different management, mainly pharmacological, are used in patients with this disorder, which depend on the final results of tests to be performed.

REFERENCES

1. Phyllis August, MD, MPH, Baha M Sibai, MD. Preeclampsia: Clinical features and diagnosis. UpToDate: Charles J Lockwood [Consultado 29 Oct 2019]. Disponible en: https://www.uptodate.com/contents/preeclampsia-clinical-features-and-diagnosis

2. Peraçoli JC, Borges VTM, Ramos JGL, Cavalli RDC, Costa SHDAM, Oliveira LGD, Souza FLPD, Korkes HA, Brum IR, Nascimento MLCD, Corrêa Junior MD, Sass N, Diniz ALD, Cunha Filho EVD. Preeclampsia/ Eclampsia. Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics. 2019 05;41(05):318-332. https://doi.org/10.1055/s-0039-1687859

3. José Geraldo Lopes Ramos, Nelson Sass, Sérgio Hofmeister Martins Costa. Preeclampsia. Thieme open Access. Ago 2017. http://dx.doi.org/10.1055/s-0037-1604471.

4. M. José Alcaine Villarroyaa, Eva M. Barrenechea Iparraguirre Elena Casals, Concepción González Rodríguez, Inmaculada Martín Navas, Hada Macher Manzano, M. Concepción Martínez Camarasaa, Daniel Morell García , Helena Méndez Sol, Irene Rosas Allende , Elvira Tejedor Hernández y Belén Prieto García. Utilidad de los marcadores bioquímicos de preeclampsia. Revista del Laboratorio Clinico. 29 Jul 2018. https://doi.org/10.1016/j.labcli.2018.06.001

5. Errol R Norwitz, MD, PhD, MBA, Federica Bellussi, MD. Early Pregnancy prediction of preeclmapsia. UpTuDate: Charles J Lockwood [Consultado 17 Sep 2019]. Disponible en: https://www.uptodate.com/contents/early-pregnancy-prediction-of-preeclampsia

6. Phyllis August, MD, MPH, Arun Jeyabalan, MD, MSCR. Preeclampsia: Prevention. UpToDate: Charles J Lockwood [Consultado 25 Feb 2019]. Disponible en: https://www.uptodate.com/contents/preeclampsiaprevention

7. Greene MF, Solomon CG. Aspirin to Prevent Preeclampsia. New England Journal of Medicine. 2017 08 17;377(7):690-691. https://doi.org/10.1056/nejme1708920

8. Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides KH. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. New England Journal of Medicine. 2017 08 17;377(7):613- 622. https://doi.org/10.1056/nejmoa1704559

9. Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: systematic review and metaanalysis. American Journal of Obstetrics and Gynecology. 2018 03;218(3):287-293.e1. https://doi.org/10.1016/j.ajog.2017.11.561

10. Cabrera Ruilova JD, Pereira Ponton MP, Ollague Armijos RB, Ponce Ventura MM. Factores de riesgo de preeclampsia. RECIAMUC. 2019 04 30;3(1):1012- 1032. https://doi.org/10.26820/reciamuc/3.(2).abril.2019.1012-1032

11. S Ananth Karumanchi, MD, Kee-Hak Lim, MD, Phyllis August, MD, MPH. Preeclampsia: Pathogenesis. UpTuDate: Vincenzo Berghella, MD [Consultado 18 Sep 2019]. Disponible en: https://www.uptodate. com/contents/preeclampsia-pathogenesis

12. Valdés G. Preeclampsia y enfermedad cardiovascular: un enfoque integral para detectar las fases subclínicas de complicaciones obstétricas y cardiovasculares. Revista chilena de cardiología. 2019 08;38(2):132-145. https://doi.org/10.4067/s0718-85602019000200132

13. Reese JA, Peck JD, Deschamps DR, McIntosh JJ, Knudtson EJ, Terrell DR, Vesely SK, George JN. Platelet Counts during Pregnancy. New England Journal of Medicine. 2018 07 05;379(1):32- 43. https://doi.org/10.1056/nejmoa1802897

14. Errol R Norwitz, MD, PhD, MBA. Preeclampsia: Management and prognosis. UpToDate: Charles J Lockwood. [Consultado 04 Sep 2019]. Disponible en: https://www.uptodate.com/contents/preeclampsiamanagement- and-prognosis

15. David Gaus, Alicia Guevara, Diego Herrera. Preeclampsia / Eclampsia. Práctica Familiar Rural. Marzo 2019. https://doi.org/10.23936/pfr.v4i2.105

16. Phyllis August, MD, MPH. Management of hypertension in pregnant and postpartum women. UpToDate: Charles J Lockwood, MD, MHCM, George L Bakris, MD. [Consultado 04 Nov 2019]. Disponible en: https://www.uptodate.com/contents/management-of-hypertension-in-pregnant-and-postpartum-women